Pharmactive Biotech established as B Corporation
The designation affirms the Spanish company’s dedication to upholding set standards in social and environmental performance, transparency, and accountability.
The B Corp standard measures management performance across the whole company, covering five key impact areas: governance, employees, community, environment, and customers.
To achieving prescribed levels in these areas companies must pass a rigorous assessment process and provide tangible evidence of good practice.
“We always consider the social and environmental impact of our activities and have adopted a legal entity that requires all stakeholders to be considered in the decision-making process,” says Jean-Marie Raymond, CEO of Pharmactive Biotech Products.
“We believe this is an important aspect to ensure the success, continuity, and profitability of our business. Our mission is to bring to market innovative products of natural origin that promote wellbeing, while having a positive social and environmental influence.”
Pharmactive uses natural proprietary extraction processes via eco-friendly techniques that use no alcohol-based elements or synthetic additives.
The process involves limited industrial processing, has low energy consumption, and produces minimal waste. The firm operates on 100% renewable electricity and recycles the water used during the extraction of its active ingredients. Additionally, the company ships its products in 100% recycled cardboard containers.
On the social and economic front, the business boasts a 60% women-powered workforce with half of the management team being female.
It also actively contributes to the development of the communities in which it operates. For example, the company works with local farmers in the area of Las Pedroñeras, in Castilla-La Mancha, where garlic, the raw material for ABG10+, its aged black garlic extract, is grown. Running solidarity activities within the community, Pharmactive maintains a close relationship with suppliers and encourages flexible working hours to help its employees balance work and family life.
Pablo Sanchez, CEO of B Lab Spain, adds: “We are delighted to welcome Pharmactive to the B Corp community, a movement that includes more than 7,000 companies from around the world that are leading a new way we conduct business and who believe they can truly be a force for the global good.
"Pharmactive is a prime example of how these results can be achieved. The company’s commitment to doing business differently will inspire others and really help spread the idea that we can redefine success in business to be as much about people and the planet as it is about profit.”
Pharmactive Biotech Products
Pharmactive Biotech Products is a leader in the research and development of scientifically supported natural botanical ingredients for the health and wellness industry.
Just a few of the firm's branded ingredients include: Affron, said to be the first saffron extract (Crocus sativus L.) clinically-backed to reduce anxiety and depression symptoms in teenagers; AffronEYE (Crocus sativus L.), standardised to 3% crocins, the major carotenoids of saffron, for eye health; KWD+ kiwi extract (Actinidia deliciosa) for vegan sports nutrition consumers as well as ageing populations at risk of muscle loss; CSAT+, a blend of carob bean extracts (Ceratonia siliqua L.), for weight management; and Liboost, a damiana extract (Turnera diffusa) standardised to ≥1.5% bioflavonoids by HPLC plus three biomolecules, for sexual health.
